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Attenuated Salmonella has been used as a carrier for DNA vaccine. However, in vitro and in vivo studies on the bacteria following
transfection of plasmid DNA were poorly studied. In this paper, eukaryotic expression plasmids encoding avian inﬂuenza virus
(AIV) subtype H5N1 genes, pcDNA3.1/HA, NA, and NP, were transfected into an attenuated Salmonella enteric typhimurium
SV4089. In vitro stability of the transfected plasmids into Salmonella were over 90% after 100 generations. The attenuated
Salmonella were able to invade MCF-7 (1.2%) and MCF-10A (0.5%) human breast cancer cells. Newly hatched speciﬁc-pathogen-
free (SPF) chicks were inoculated once by oral gavage with 109 colony-forming unit (CFU) of the attenuated Salmonella.N o
abnormal clinical signs or deaths were recorded after inoculation. Viable bacteria were detected 3 days after inoculation by plating
from spleen, liver, and cecum. Fluorescent in situ hybridization (FISH) and polymerase chain reaction (PCR) were carried out
for conﬁrmation. Salmonella was not detected in blood cultures although serum antibody immune responses to Salmonella O
antiserum group D1 factor 1, 9, and 12 antigens were observed in all the inoculated chickens after 7 days up to 35 days. Our results
showed that live attenuated S. typhimurium SV4089 harboring pcDNA3.1/HA, NA, and NP may provide a unique alternative as a
carrier for DNA oral vaccine in chickens.
1.Introduction
Avian systemic salmonellosis has three distinct phases and
during each phase there is signiﬁcant interaction with the
immune system. The ﬁrst is invasion via the gastroin-
testinal tract. The second phase is the establishment of
systemic infection mainly as an intracellular infection of
macrophages. Finally infection may be cleared by the
immune response, the bird may succumb to the infection,
or a subclinical carrier state may develop [1].
It has been established that attenuated Salmonella enter-
ica serovar Typhi (S. Typhi) strains can serve as safe and eﬀ-
ective oral vaccines to prevent typhoid fever [2]. In addition,
live attenuated S. typhimurium strains have been evaluated
for use as live vaccines to express or deliver a variety
of pathogen’s antigen or DNA, respectively, to mucosal
lymphoid tissue including the HA of avian inﬂuenza virus
(AIV) [3], polyprotein of infectious bursal disease virus
(IBDV) [4], VapA antigen of Rhodococcus equi [5], and
5401 gene of Eimeria tenella [6]. In all the above studies,
oral administration of the attenuated Salmonella may induce
immune response with various degrees of protection against
the respective pathogens.
The pathogenicity of the bacteria such as S. typhimurium
can be reduced signiﬁcantly by various attenuation methods
while still retaining their invasion capacity and thus deliver
the heterologous genes into mammal cells. S. typhimurium
SV4089 is a double mutant (Dam− and PhoP−), derived
from wild-type S. typhimurium SL1344. This mutant of
Salmonella did not show pathogenicity to chickens at a
dose level as high as 1010 CFU/mL delivered orally [4,
6]. The oral LD50 determined for chicken, of wild-type
SL1344, is about 104 CFU [7]. Studies have shown that Dam
methylationregulatesothervirulence-relatedlocibesidesspv
genes in the virulence plasmid such as LPS modiﬁcation
genes, Salmonella pathogenicity island 1, and the std ﬁmbrial2 Journal of Biomedicine and Biotechnology
Table 1: Primers used for ampliﬁcation of HA, NA, and NP of A/Ck/Malaysia/5858/04 (H5N1) in pcDNA3.1 vectors.
Primer Sequence (5  to 3 )G e n e T m ( ◦C)
HAF ccc caa GCT TAT GGA GAA AAT AGT GCT T HA 58.5
HAR ccc gga GGA TCC AAT GCA AAT TCT GCA TTG TAA HA 63.2
NAF ccc caa CAA GCT TAT GAA TCC AAA TAA GAA NA 57.5
NAR ccc gaa TTC CTT GTC AAT GGT GAA TGG NA 59.7
NPF aaa aag CTT ATG GCG TCT CAA GGC ACC NP 59.7
NPR ggg gga TCC ATT GTC ATA TTC CTC TGC NP 61.3
Extra six nucleotide bases in lower case were added before recognition sites to facilitate ampliﬁcation.
operon are under Dam methylation control [8, 9], whilst
PhoP-PhoQ is regulatory system that controls expression of
several virulence properties in S. typhimurium [10]. In addi-
tion, the virulence possessions that the PhoP− PhoQ system
controls include the ability to survive inside macrophages,
withstanding acidic pH, invasion of epithelial cells, con-
frontation of killing by antimicrobial peptides, formation of
spacious vacuoles, and the ability to alter antigen presenta-
tion [11].
Although S. typhimurium has successfully been used
as a carrier for vaccine, characteristics of the bacteria and
its in vitro and in vivo stability in chickens are poorly
studied. Hence, the purpose of this study is to characterize
the attenuated S. typhimurium SV4089 transfected with
eukaryotic expression plasmid encoding AIV genes.
2.MaterialsandMethods
2.1. Attenuated Salmonella, Media, and Reagents. Attenu-
ated Salmonella enterica sv. Typhimurium (S. typhimurium)
SV4089waskindlyprovidedbyDr.JosepCasadesus(Depart-
ment of Molecular Genetics University of Sevilla Spain).
The bacteria is a double mutant (dam−228::MudJ (Dam−)
phoP7953::Tn10 (PhoP−)), derived from wild-type S. typh-
imurium SL1344 [4, 6]. Bacterial strains were cultured in
Luria Bertani (LB) broth or agar. The eukaryotic expression
plasmids, pcDNA3.1 (Invitrogen, USA) expressing AIV
subtype H5N1 A/Ck/Malaysia/5858/04, HA, NA, and NP
genes (pcDNA3.1/HA, NA, and NP) were constructed by
Jalilian et al. [12]. The nucleotide sequences of the full
length of HA, NA, and NP are available at GenBank under
accession number DQ320934, DQ321066, and DQ321132,
respectively.
2.2. Transformation of S. typhimurium. A single colony of
attenuated S. typhimurium SV4089 was grown in LB broth
to an optimal density OD600 0.6–0.8 and resuspended in
ice-cold Nuclease-Free Water. The plasmids pcDNA3.1/HA,
NA, NP and control plasmid (pcDNA3.1) were puriﬁed
(Qiagen, Germany) and transformed into S. typhimurium
competent cells by electroporation set at 2.5kV, 25µF, and
200–400Ω (Gene Pulser, Bio-Rad, USA). The transformed
culture (100µL) was suspended into LB plates supplemented
with50µg/mL ampicillin [4, 6]. Resistant colonies harboring
the plasmid were cultured and stored after conﬁrmation by
PCR and FISH to the targeted AIV HA, NA, and NP.
2.3.StabilityofPlasmidsinS.typhimurium. Todeterminethe
in vitro stability of the transfected plasmid in a population of
attenuated S. typhimurium, bacterial cultures were passaged
for approximately 100 generations (25 days) without antibi-
otic selection. The percentage stability of the plasmid was
estimated by calculating the number of cells containing the
plasmidateachpassagedividedbythenumberofSalmonella.
2.4. Invasion Assay of Salmonella on Eukaryotic Cells. The
human breast cancer cell lines, MCF-7 and MCF-10A,
were maintained in Dulbecco’s Modiﬁed Eagles Medium
(DMEM) with 10% (v/v) fetal calf serum and 10% (v/v)
antibiotic and antimycotic (GIBCO, Invitrogen, USA) then
infected with S. typhimurium as described by Cano et al. [13]
withmodiﬁcation.Brieﬂy,106 CFUofbacteriawereaddedto
thecellcultureat60to70%conﬂuencyin24-wellplateswith
each well containing 105 cell, multiplicity of 10:1 infection
(bacterium/eukaryotic cell ratio). After incubation for 1h,
extracellular bacteria were killed by incubation for 2h at
37◦C in DMEM containing 100µg of gentamicin/mL. Cells
were washed three times in phosphate-buﬀered saline (PBS),
pH 7.4, and lysed with 1% Triton X-100-PBS (pH 7.4) for
5minatroomtemperature.Viablecountsoftheintracellular
bacteria in the lysate were made on LB agar. All samples were
run at least in duplicates.
2.5. PCR Ampliﬁcation of Targeted AIV Genes. As e to f
primers were designed based on the consensus sequences for
ampliﬁcation of HA, NA, and NP genes of A/Ck/Malaysia/
5858/04 (H5N1) (Table 1). Ampliﬁcation was facilitated by
an additional 6bp to the 5  end of the primer. Gene
fragments of interest were ampliﬁed by gradient PCR using
a PCR Thermal Cycler (MJ Research, PTC-225). Brieﬂy,
in a 50µL volume, 25µLd H 2O was mixed with 1.5µL
of 10X reaction PCR buﬀer, 0.6µLo f5 0 m MM g C l 2,
0.6µL of dNTP mix (10mM each), 10µL each of 100mM
forward and reverse primers, 0.3µL Taq DNA polymerase (5
U/µL) (Vivantis, Malaysia), and 2µL (50ng) template. The
ampliﬁcation was performed in a PCR thermal cycler using
the following parameters: one cycle of 94◦C for 5min; 30
cycles of 94◦C for 1min, 56.9◦C for 1min, 72◦C for 2min,Journal of Biomedicine and Biotechnology 3
Table 2: Speciﬁc labeled probes used for the detection of AIV genes.
Sequence (5  to 3 ) Gene
Cy5 atg GAG AAA ATA GTG CTT CTT TTT GCA ATA HA
Alexa 350 atg AAT CCA AAT AAG AAG ATA ATA ACC ATC NA
Fluoatg GCG TCT CAA GGC ACC AAA CGA TCT TAT NP
To facilitate binding of probe and labeling with dye, an additional 3bp (atg) were added to the 5  end of the primer.
ﬁnal extension step of 72◦C for 10min, and a hold cycle at
4◦C.
2.6.PCRDetectionofAttenuatedS.typhimurium. PCRassays
wereconductedbasedonthedetectionofRandomAmpliﬁed
Polymorphic DNA (RAPD) as described by Gurakan et al.
[14]. Brieﬂy, in a 50µL reaction, 27µLd H 2Ow a sm i x e dwi t h
10µL (50ng) template, 0.6µLo f5 0 m MM g C l 2;1 . 5 µLo f
10X reaction PCR buﬀer; 0.6µL 0f 10mM deoxynucleoside
triphosphate; 0.3 U of Taq D N Ap o l y m e r a s e( V i v a n t i s ,
Malaysia); 10µLo f1 0 m Mp r i m e r5  -CGT GCA CGC-3 
[14].Thereactionmixturewasdenaturatedat90◦Cfor5min
followed by 35 × [89◦C, 1min; 32◦C, 1min; 72◦C, 1.5min],
an extension cycle at 50◦Cf o r3m i n ,a n dah o l dc y c l ea t4 ◦C.
The PCR product and loading dye were mixed and separated
on 1% agarose gel with 1X TAE buﬀer (Promega, Germany)
at 80V for 40min.
2.7. FISH Detection of Transfected Plasmid and Salmonella.
The targeted HA, NA, and NP genes in transfected
Salmonella were detected using speciﬁcally designed and
labeled HA, NA, and NP probes (Table 2) by FISH. Mean-
while, a speciﬁc probe for the 23S rRNA of Salmonella
was used, Sal3 (5 -AATCACTTCACCTACGTG-3 )[ 15, 16]
to detect the attenuated S. typhimurium.T h ep r o b ew a s
synthesized and labeled with Cy5 at the 5  end (NextGene,
Germany).
Brieﬂy, Salmonella and Salmonella/pcDNA3.1/HA, NA,
and NP were ﬁxed and hybridized using the protocol
described by Tabatabaei et al. [17] with some modiﬁcation.
T h ec e l l s( 2 m L )w e r eﬁ x e di n6 m Lo f3 %p a r a f o r m a l d e -
hyde/phosphatebuﬀersaline.Theﬁxedcellsuspensionswere
diluted with ethanol/PBS mixture (1:1) and were spotted on
coatedglassslides(Cel-Line,NewHampshire,UK).Bacterial
smears were covered with 20µL of lysozyme, incubated
for 20min at 30◦C. The slides were thoroughly rinsed
with double-distilled water followed by air-drying at room
temperature for the termination of enzymatic digestion.
Samples in 8µL of hybridization buﬀer and 1µLo f
Sal3, HA, NA, and NP probe were separately applied to the
wells on the slides and incubated. Unbound probes were
removed by rinsing the slide in 1mL of washing solution.
The slides were then incubated at 48◦Cf o r2 0 m i ni n
50mLofwashingsolution, rinsedbrieﬂywithdistilledwater,
air-dried, and mounted with SlowFade antifading reagent
(Molecular Probes, OR, USA). Fluorescence was observed
using confocal laser microscopy (MRC 1024ES, BioRad,
USA).
2.8. Preparation of Salmonella Inocula. The inocula were
prepared from typical Salmonella (clear with black center
on XLT4) colonies of an overnight culture, which were
transferred 3 times in LB medium. The bacterial cells were
collected by centrifugation at 5000×gf o r1 0m i na n ds e r i a l l y
diluted in sterile Buﬀered Peptone Water (BPW) (pH 7.2) to
a concentration of approximately 109 CFU/mL.
2.9. Bacteriological Analysis of SPF Chickens. Eighteen-day-
old SPF eggs were purchased from Malaysian Vaccines and
Pharmaceuticals and reared under Salmonella-free environ-
ment. Cloacal swabs from one-day-old SPF chicks were
directly preenriched in BPW at 37◦C for 24h, after which
the samples were enriched by the addition of 1mL of this
suspension to 9mL of Rappaport-Vassiliadis 10 broth (AES
Lab,India).Followingtheincubationat42◦Cfor20h,100µL
of this suspension was inoculated on XLT4 (AES Lab, India)
plates with novobiocin (25µg/mL)/nalidixic acid (20µg/mL)
(NO-NA) of culture media and incubated for 20h at 37◦C.
2.10. Inoculation of SPF Chickens with Attenuated Salmonella.
Newly hatched chickens were subjected to oral inoculation
with attenuated Salmonella using an autoclaved gavage
plastic tube and a 1mL syringe. The inocula were drawn
through the gavage plastic tube, which was then dipped
in glycerol for a smoother passageway down the chicken
esophagus. A dose of 500µL containing approximately 109
cells was administered orally to each chick. Chickens were
monitored daily for clinical changes and were provided free
access to water and a balanced unmedicated corn-soybean-
meal-basedmashlayerdietthatmetorexceededtheNational
Research Council (NRC) requirements for nutrients. The
experimental trials were approved by the animal care and use
committee at the Faculty of Veterinary Medicine, Universiti
Putra Malaysia, UPM/FPV/PS/3.2.1.551/AUP-R72.
2.11. Clinical and Bacteriologic Surveillance. During the
period of clinical observation, four chickens at day 3, 5, 7,
10, 14, 21, 28, and 35 were euthanized for sample collection.
Cecum, liver, heart, and spleen were collected in sterile
condition and homogenized, and 10-fold dilutions were
madeinBPWstartingfrom10to10,000.Fromeachdilution,
100µL samples were cultured on NO-NA XLT4 plates. The
number of CFU/g of tissue was determined by counting
the bacterial colonies. Five colonies of bacteria were picked
randomly at each time point for PCR identiﬁcation. Multiple
blood cultures were also obtained after inoculation to detect
bacteremia.Freshlycollectedbloodweredirectlypreenriched4 Journal of Biomedicine and Biotechnology
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Figure 1: In vitro stability of pcDNA3.1/HA, NA, NP, and
pcDNA3.1. Recombinant S. typhimurium containing transfected
plasmids were passaged for approximately 100 generations. The
percentage of bacteria containing the plasmid was determined by
viable count on media without the appropriate antibiotic selection.
No signiﬁcant diﬀerence was recorded (P> 0.05).
and enriched with BPW and Rappaport-Vassiliadis 10 broth
(AES Lab, India). One milliliter of this culture was then
plated on NO-NA XLT4 and incubated for 20h at 37◦C, and
examined for growth. Blood was collected for serum slide
agglutination of antibodies to Salmonella O antiserum group
D1 (factors 1, 9, 12) (Difco, Becton Dickinson, USA).
3. Results
3.1. Characterization and Antibiotic Resistance of Salmonella
Colony on XLT4. Plating results of S. typhimurium SV4089
on XLT4 provide good presumptive morphologic evidence
for the presence of Salmonella species. Colonies on XLT4
plate typically are large, black with a creamy margin (after
30h) and circular, with convex to umbonate/nippled eleva-
tions and entire margins. Both the nontransfected as well as
pcDNA3.1, pcDNA3.1/HA, pcDNA3.1/NA, and pcDNA3.1/
NP transfected attenuated S. typhimurium SV4089 are NO-
NA resistant.
3.2. In Vitro Invasion Assay of Attenuated Salmonella into
Mammalian Cells. The average invasion rate obtained in
standard 60min infection was 1.2% ± 0.09 in MCF-7 and
0.5% ±0.08 in MCF-10A cells.
3.3.InVitroStabilityofpcDNA3.1/HA,NA,NP,andpcDNA3.1
in S. typhimurium. S. typhimurium SV4089 transfected with
pcDNA3.1/HA, NA, NP and pcDNA3.1 were grown without
antibiotic and each point represents the percentage of
bacterial population that has retained the plasmid. The
plasmid was stably detected over 90% of the attenuated S.
typhimurium population after 100 generations of growth in
antibiotic-free media (Figure 1).
3.4. PCR Screening of HA, NA, and NP, for Salmonella after
Transfection. PCR screening of the transfected Salmonella
showed that pcDNA3.1/HA, pcDNA3.1/NA and pcDNA3.1/
M1 23 45 6 7 8
∼ 1.7kb
∼ 1.5kb ∼ 1.6kb
Figure 2:PCRampliﬁcationofHA,NAandNP,genesofpcDNA3.1
vector from transfected S. typhimurium.M= 100bp marker
(Fermentas, Germany) lane 1–3 = HA; 4-5 = NA; 6–8 = NP.
M1 2 3 4
∼ 6.8kb∼ 6.6kb ∼ 6.7kb
∼ 5.1kb
Figure 3: Extracted circular plasmids from transfected Salmonella:
M = 1kb marker (Fermentas, Germany); 1 = pcDNA3.1/HA; 2 =
pcDNA3.1/NA; 3 = pcDNA3.1/NP; 4 = pcDNA3.1.
NP from transfected Salmonella were successfully trans-
formed into attenuated S. typhimurium cells separately. The
viral HA, NA and NP genes of A/Ck/Malaysia/5858/04
(H5N1) virus were ampliﬁed from the respective transfected
Salmonella by PCR. Figures 2 and 3 showed the expected
sizes of the ampliﬁed product for HA (1.7kb), NA (1.5kb),
NP (1.6kb) and circular pcDNA3.1 (5.1 kb), pcDNA3.1/HA
(6.8kb), pcDNA3.1/NA (6.6kb), pcDNA3.1/NP (6.72kb),
respectively.
3.5. Clinical and Bacteriologic Results. Cloacal swabs were
collected from one-day-old SPF chickens. No Salmonella-
positive chickens were found. To test the possibility of col-
onization of S. typhimurium SV4089 into organs, chickens
were infected orally with a dose of approximately 109 cells.
Salmonella was found in the spleen, liver, and cecum of the
infected birds after 3 days of infection.
T h es y s t e m i cc o u n t so fSalmonella-positive peaked at 7
days after infection in all the selected organs following which
they declined at day 14, where no bacteria were detected in
those organs although Salmonella showed good stability in
cecum until day 35 (data not shown). No Salmonella growth
was detected in the heart. As expected, the control group
was Salmonella-free throughout the experiment. Antibody
against Salmonella was detected by adding one drop of
Salmonella O antisera group D1 with one drop of the
collected serum on a slide. Although, Salmonella were not
detected in blood cultures, sera from inoculated chickens
from as early as 7 days of vaccination up to 35 days were
detected positive for Salmonella-speciﬁc antibodies.
3.6. FISH of the Transfected Plasmid and Salmonella. Under
optimal hybridization conditions, transfected HA, NA and
NP genes into Salmonella were speciﬁcally visualized and
detected using the corresponding probes (Figure 4). Mean-
while, Salmonella was speciﬁcally detected using genus-
speciﬁc probe, Sal3 from homogenized spleen, liver andJournal of Biomedicine and Biotechnology 5
(a) (b)
(c) (d)
Figure 4: FISH detection of HA, NA and NP. (a) pcDNA3.1/HA, (b) pcDNA3.1/NA, (c) pcDNA3.1/NP, (d) pcDNA3.1 as negative control
after transfected into S. typhimurium strain SV4089 by confocal laser microscopy. Probes were labeled with Cy5 (red), Alexa 350 (blue) and
Fluo (green) ﬂuorescent dye, respectively. The white bar in each image represents 2µm.
(a) (b) (c)
Spleen
(d)
(e) (f) (g)
Liver 
(h)
(i) (j) (k)
Cecum
(l)
Figure 5: FISH detection of Salmonella from infected homogenized spleen after (a) 3 days, (b) 7 days, (c) 10 days, (d) negative control, liver
after (e) 3 days, (f) 7 days, (g) 10 days, (h) negative control, cecum after (i) 3 days, (j) 7 days, (k) 21 day, (l) 35 days infection. The white bar
in each image represents 2µm.
cecum sections of infected chicken, whereby a distinct ﬂu-
orescent signal from rod-shaped bacteria could be detected
following hybridization (Figure 5). Salmonella was detected
from infected organs (spleen, liver and cecum) 3 days after
inoculation. After two weeks, the infected chickens showed
good clearance of Salmonella from spleen and liver, while
Salmonella w e r ed e t e c t e di nc e c u me v e na t3 5d a y sa f t e r
inoculation.
3.7. PCR of Salmonella . Detection of Salmonella using PCR
wasperformedusinggenus-speciﬁcprimersforrapidscreen-
ing of pure culture and extracted Salmonella from tissue.6 Journal of Biomedicine and Biotechnology
M12345 6 78
∼ 700bp
Figure 6: Ampliﬁcation results of S. typhimurium from homog-
enized infected organs; 1-2 = spleen and liver after 7 days; 3-4 =
spleen and liver after 10 days; 5-6 = cecum after 10 and 35 days; 7 =
negative control; 8 = positive control. M = 1kb marker (Fermentas,
Germany). Detection of 700bp ampliﬁcation product was found as
speciﬁc polymorphic marker for S. typhimurium. Arrows indicate
500bp and 1,000bp DNA fragments.
As shown in Figure 6, the RAPD patterns contained three
diﬀerent bands, in which the size varied between 300 and
1,000bp. The presence of 700bp ampliﬁcation product was
found as speciﬁc polymorphic region for S. typhimurium.
4. Discussion
A major disadvantage of DNA vaccine is its low eﬃciency,
which is inherent in the way the vaccine is currently being
administered.Inaddition,parenteraladministrationofDNA
vaccineisnotpracticalinlivestockanimalsincludingpoultry
thatrequiresmassvaccination.Thus,itisessentialtodevelop
carrier systems that improve eﬃcacy of genetic vaccines.
Live bacteria that contain recombinant plasmids encoding
heterologous antigen genes from other pathogens have the
potential as oral delivery vectors for DNA vaccines. The
pathogenicity of bacteria such as S. typhimurium could
be decreased signiﬁcantly by various attenuation methods
while still retaining their invasion capacity to deliver the
heterologous genes into mammalian cells [13]. A few studies
in chickens have shown that S. typhimurium harboring
heterologous genes were capable of eliciting speciﬁc humoral
and cellular immune responses locally and at the systemic
level [4, 6]. However, characterization studies on attenuated
Salmonella as DNA vaccine carrier in chicken is limited.
In this study, the characteristics of the attenuated S.
typhimurium SV4089/harboring pcDNA3.1, pcDNA3.1/HA,
NA, and NP gene were investigated. First, the transfected
bacteria were genetically stable in vitro when passing on LB
agar with or without antibiotic selection as well as on XLT4
agar. Secondly, PCR, FISH, and culturing on XLT4 were
able to detect Salmonella from homogenized spleen, liver,
and cecum. No chickens displayed any clinical aberrations,
side eﬀects, and abnormalities after inoculation with the
attenuated Salmonella at dose of 109 CFU within 5 weeks
after oral inoculation. Previous studies have shown that
the attenuated bacteria are not pathogenic to chickens at
dose levels as high as 1010 CFU/mL delivered orally [4, 6].
However, the virulent strain of the Salmonella SL1344 has an
oral LD50 of 104.
Salmonella colonize the small intestine and invade nor-
mally nonphagocytic epithelial cells in order to gain access
to the underlying lymph tissue. Invasion is mediated by
a type III secretion system (T3SS) encoded on Salmonella
pathogenicity island 1 (SPI1). The SPI1 T3SS forms a
needle-like complex that is responsible for the injection of
bacterial eﬀector proteins into the host cell cytosol [18].
Another important hallmark of Salmonella pathogenesis is
resistance to antimicrobial attack of phagocytic cell [13].
ThesemechanismsenableserovarTyphimuriumto eﬃciently
go through the intestinal epithelial barrier and distribute
to deeper tissues. The lack of PhoP-PhoQ two-component
systemhasalwaysbeenlinkedtomajorintramacrophagesur-
vival defects and marked attenuation in the murine typhoid
model. Hence, human cancer cell lines are commonly used
to study invasion of Salmonella to eukaryotic cells [19]. The
attenuated Salmonella used in this study still maintained its
ability to invade MCF-7 and MCF-10A mammalian cells,
where 1.2% and 0.5% of the cells were infected, respectively.
In addition, in vitro study of Salmonella serovar Enteritidis
phage type 4, strain 76Sa88 showed invasion into T84
human colonic adenocarcinoma cell line up to 5.75% [20].
Meanwhile, the average invasion rate of Salmonella enterica
serovar Typhimurium strains into HeLa cells and NRK-49F
rat ﬁbroblasts was up to 1-2% and 0.2–0.5%, respectively
[13].
In order to enhance the speciﬁcity and sensitivity of S.
typhimurium SV4089 detection among the other Enterobac-
teriaceae in the gastrointestinal tract, XLT4 media is uniquely
formulated with surfactant, tergitol [21]. In this study, XLT4
media supplemented with NO-NA could serve as a selective
medium for S. typhimurium SV4089. In addition, we showed
that initial resuscitation of Salmonella in selective medium
with NO-NA followed by other detection methods such as
PCR and FISH is eﬀective to avoid any-false positive results.
Previously, G¨ urakan et al. [14] have used RAPD analysis to
detect S. typhimurium from other selected Enterobacteriaceae
andshowedspeciﬁcbandforthedetectionofS.typhimurium
is700bp.Usingsimilarapproach,a700bpbandwasdetected
in smear and infected organs of S. typhimurium SV4089.
The safety of a live vaccine and stability of an expression
plasmid in a vaccine vector may potentially aﬀect the eﬃcacy
of the vaccine and alter the outcome of vaccination. One
of the limitations of using bacteria especially Salmonella
as a carrier is monitoring the stability and availability of
bacteria without any cultivation. Our study demonstrated
that 5  monolabeled DNA oligonucleotide is able to detect
plasmid DNA in prokaryotes without signal ampliﬁcation-
based or target ampliﬁcation by in situ RT-PCR (Figure 4).
The fact that FISH can detect nonculturable bacteria is an
advantage. A 23S rRNA FISH method, using Sal3 probe was
used as a rapid and direct screening tool on attenuated S.
typhimuriumSV4089inpurecultureandtissuehomogenates
from chickens inoculated with Salmonella (Figure 5). The
method allowed us to detect the bacteria from tissues of the
inoculated chickens within approximately 7h prior to the
culture of Salmonella (necessary time for ﬁxation, hybridiza-
tion, and observation of the sample) [22–24]. In this study,
rod-shaped Salmonella was detected from homogenized
spleen, liver, and cecum as early as 3 days after inoculation.
The Salmonella count peaked at day 7 although at day 14 no
bacteria were detected in those organs except from cecum.
Previous study has shown that S. enteritidis aroA invadesJournal of Biomedicine and Biotechnology 7
phagocytes of the liver, spleen, and bone marrow [25]. In
addition, extensive bacterial multiplication occurred in the
ceca. Clearance of S. typhimurium from the gastrointestinal
tract occurred considerably later than the clearance from
the spleen and liver [26, 27]. The results presented here
indicate that although attenuated S. typhimurium SV4089
is able to move through diﬀerent organs of chicken, it is
not able to cause septicemia. In addition, sera from the
inoculated chickens react strongly with O antiserum group
D1 indicating the attenuated Salmonella is a suitable vaccine
candidate for oral vaccination.
Salmonella has been used as live vehicles for inducing
protective responses to a wide variety of diseases since
due to its ability to improve vaccine eﬃcacy by targeting
vaccinesinvivoinductivesitesonmucosalsurfaceorinternal
organs. The growth of the live bacteria can also be controlled
by common antibiotics. In addition, Salmonella naturally
possesses LPS that can function as an adjuvant to stimulate
systemic immune responses [28].
In conclusion, live attenuated Salmonella serovar Typh-
imurium provides a unique alternative in terms of in vitro
stability of transfected plasmid, in vivo stability, relatively
inexpensive to produce in large scale, and easy detection by
acting as a carrier in chickens.
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